Results 1 to 10 of about 1,090 (156)

Awareness of the European Group on Graves’ Orbitopathy (EUGOGO) Guidelines and Their Practical Usage in Croatia: An EUGOGO Pilot Study [PDF]

Acta Clinica Croatica
This pilot study aimed to evaluate the awareness and practical usage of the European Group on Graves’ Orbitopathy (EUGOGO) Guidelines in Croatia, in view of a possible EUGOGO survey on a larger scale. A 27-question anonymous online questionnaire survey
Maja Baretić, Jelena Juri Mandic, Lelio Baldeschi   +2 more
exaly   +6 more sources

Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves’ orbitopathy [PDF]

European Thyroid Journal
Background: In 2021, the European Group on Graves’ orbitopathy (EUGOGO) published clinical practice guidelines for the management of GO, and in 2022, the American and European Thyroid Associations published the ATA/ETA consensus statement on the same ...
Maria Laura Tanda, Luigi Bartalena, Daniela Gallo   +2 more
exaly   +9 more sources

Graves’ Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management [PDF]

Journal of Ophthalmology, 2015
Graves’ ophthalmopathy (GO) is an autoimmune inflammatory disorder associated with thyroid disease which affects ocular and orbital tissues. GO follows a biphasic course in which an initial active phase of progression is followed by a subsequent partial ...
Alfonso L Sabater, Jesus Barrio-Barrio, Alvaro Velázquez Villoria   +2 more
exaly   +10 more sources

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement [PDF]

Orphanet Journal of Rare Diseases, 2017
Background Graves’ orbitopathy (GO) is an autoimmune condition, which is associated with poor clinical outcomes including impaired quality of life and socio-economic status.
Petros Perros, Luigi Bartalena
exaly   +18 more sources

A Korean Clinical Practice Framework for Thyroid Eye Disease: Integrating International Recommendations with Survey-Informed Consensus [PDF]

Endocrinology and Metabolism
Thyroid eye disease (TED), the most common extrathyroidal manifestation of Graves’ disease, requires individualized management that integrates medical, radiotherapeutic, and surgical interventions.
JaeSang Ko, Dongheon Surl, Min Joung Lee, Jeong Kyu Lee, JunHyuk Son, Namju Kim, Jaewook Yang, Jin Sook Yoon   +7 more
doaj   +2 more sources

Multidisciplinary management of thyroid eye disease (TED) in patients with latent tuberculosis or chronic hepatitis B [PDF]

Thyroid Research
Background Intravenous methylprednisolone (IVMP) is a first-line treatment for active moderate-severe or sight-threatening thyroid eye disease (TED), but the presence of systemic infections such as latent tuberculosis (TB) or chronic hepatitis B virus ...
John S. Vekinis, Jonathan Lee, Vickie Lee, Ahmad Aziz, Rajni Jain, Claire Feeney, Vassiliki Bravis   +6 more
doaj   +2 more sources

Cross-sectional study of thyroid associated orbitopathy in a South African thyroid clinic [PDF]

Journal of the Colleges of Medicine of South Africa
Background: Thyroid-associated ophthalmopathy (TAO) is a common and debilitating manifestation of Graves’ disease (GD) associated with poor clinical outcomes including impaired quality-of-life (QoL) and socio-economic status.
Sandra De Vasconcelos, Hamzah Mustak, Maanda Mabogo, Joel Dave   +3 more
doaj   +2 more sources

Thyroid Eye Disease Following SARS-CoV-2 Vaccination: Experience of a Case Series [PDF]

Vaccines
Background: Thyroid eye disease (TED), or Graves’ orbitopathy, is the most common extra-thyroidal manifestation of Graves’ disease, but it has only rarely been reported after SARS-CoV-2 vaccination.
Alin Abreu Lomba, María Elena Tello-Cajiao, Mónica Morales, Alexander Martínez, Mauricio Andrés Salazar Moreno, David Alexander Vernaza Trujillo, Alice Gaibor-Pazmiño, Juan S. Izquierdo-Condoy   +7 more
doaj   +2 more sources

Lamina cribrosa curvature depth and index as novel parameters in Graves’ ophthalmopathy [PDF]

Scientific Reports
This study aims to evaluate lamina cribrosa (LC) parameters, macular ganglion cell layer thickness (GCLT) and peripapillary retina nerve fiber layer thickness (RNFLT) in Graves’ Ophthalmopathy (GO) patients using spectral domain optical coherence ...
Abdullah Ergen, Büşra Yılmaz Tuğan
doaj   +2 more sources

Immunomodulators in Graves’ ophthalmopathy: a systematic review [PDF]

Frontiers in Endocrinology
BackgroundGraves’ Ophthalmopathy (GO), or thyroid eye disease, is an extrathyroidal complication of Graves’ disease, causing a significant impact on patients’ quality of life. There are consensus statements from both the American Thyroid Association (ATA)
Antoinette Yeung, Mohammed Saqlain Siddiqui, Neginsadat Mirtorabi, Umnia Nasir Ahmed, Emma Watts, Neil Sharma, Reena Kumari, Kristien Boelaert, Jameel Muzaffar, Jameel Muzaffar, Hannah Nieto   +10 more
doaj   +2 more sources